Literature DB >> 1965149

A multiplicity of differentiation-regulated ATF site-binding activities in embryonal carcinoma cells with distinct sequence and promoter specificities.

P T Tassios1, N B La Thangue.   

Abstract

Cells of the F9 murine embryonal carcinoma (F9 EC) line have an activity that stimulates transcription from early adenovirus gene promoters. One such promoter, that of the E4 gene, is transcribed efficiently in F9 EC cells and is activated further as these cells differentiate to parietal endoderm-like cells (F9 PE). The sequences required for this in vivo regulation include the activating transcription factor (ATF)-binding site, and consistent with this we show that complexes formed on this site are regulated as F9 EC cells differentiate. Another ATF site-containing promoter is that of the human vasoactive intestinal polypeptide (VIP). In contrast to the E4 promoter, the VIP promoter is transcriptionally inactive throughout differentiation, a feature that correlates with distinct binding activities on its ATF site. We define five ATF site-binding activities in F9 cells that can be distinguished from each other by their precise sequence requirements and their regulation during differentiation. From these activities, we define those that bind in a promoter-specific or promoter-common fashion to the E4 and VIP promoters. These data indicate that members of the ATF family of transcription factors are differentiation-regulated and support the idea that they provide diverse transcriptional stimuli.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965149

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  11 in total

1.  Sequences and factors required for the F9 embryonal carcinoma stem cell E1a-like activity.

Authors:  E J Murray; D Stott; P W Rigby
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

2.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

3.  Identification of proteins that interact with CREB during differentiation of F9 embryonal carcinoma cells.

Authors:  N Masson; H C Hurst; K A Lee
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

4.  Determination of sugar conformations by NMR in larger DNA duplexes using both dipolar and scalar data: application to d(CATGTGACGTCACATG)2.

Authors:  M R Conte; C J Bauer; A N Lane
Journal:  J Biomol NMR       Date:  1996-05       Impact factor: 2.835

5.  Solution structure of the ATF-2 recognition site and its interaction with the ATF-2 peptide.

Authors:  M R Conte; A N Lane; G Bloomberg
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

6.  Transcriptional repression by the Rb-related protein p107.

Authors:  M Zamanian; N B La Thangue
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

7.  Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses.

Authors:  H J Brady; C G Miles; D J Pennington; E A Dzierzak
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation.

Authors:  F A Kruyt; G Folkers; C E van den Brink; P T van der Saag
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

9.  Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter.

Authors:  N Masson; M Ellis; S Goodbourn; K A Lee
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.

Authors:  M Zamanian; N B La Thangue
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.